Connor, Clark & Lunn Investment Management »

Cytomx Therapeutics shares owned by Connor, Clark & Lunn Investment Management

Quarter-by-quarter ownership of Cytomx Therapeutics (CTMX) shares owned by Connor, Clark & Lunn Investment Management from 13F filings

Historical chart of Connor, Clark & Lunn Investment Management investment in Cytomx Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cytomx Therapeutics held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytomx Therapeutics by Connor, Clark & Lunn Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $305k 197k 1.55
2023-09-30 $188k 146k 1.29
2023-06-30 $268k 156k 1.72
2023-03-31 $203k 134k 1.51
2022-12-31 $242k 151k 1.60
2022-09-30 $306k 211k 1.45
2022-06-30 $379k 207k 1.83
2022-03-31 $535k 200k 2.67
2021-12-31 $874k 202k 4.33
2021-09-30 $280k 55k 5.10
2021-03-31 $713k 92k 7.73
2020-12-31 $383k 59k 6.55
2020-09-30 $156k 23k 6.67
2020-06-30 $396k 48k 8.33
2020-03-31 $763k 99k 7.67
2019-12-31 $256k 31k 8.32
2017-06-30 $224k 15k 15.50